Mutations in ARID1A, ARID2, BRAF, SMARCA4, TERT and IDH1 were significantly exclusive to intracranial metastases while the same variants remained undetected in the corresponding extracranial tumor tissues. This evidence concerns the gene BRAF and neoplasm.